Document Detail


Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.
MedLine Citation:
PMID:  23139240     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Systemic juvenile idiopathic arthritis (JIA) is characterized by fevers, rash, and arthritis, for which interleukin-1 (IL-1) and IL-6 inhibitors appear to be effective treatments. Pulmonary arterial hypertension (PAH), interstitial lung disease (ILD), and alveolar proteinosis (AP) have recently been reported with increased frequency in systemic JIA patients. Our aim was to characterize and compare systemic JIA patients with these complications to a larger cohort of systemic JIA patients.
METHODS: Systemic JIA patients who developed PAH, ILD, and/or AP were identified through an electronic Listserv and their demographic, systemic JIA, and pulmonary disease characteristics as well as their medication exposure information were collected. Patients with these features were compared to a cohort of systemic JIA patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
RESULTS: The patients (n = 25) were significantly (P < 0.05) more likely than the CARRA registry cohort (n = 389) to be female; have more systemic features; and have been exposed to an IL-1 inhibitor, tocilizumab, corticosteroids, intravenous immunoglobulin, cyclosporine, and cyclophosphamide. Twenty patients (80%) were diagnosed with pulmonary disease after 2004. Twenty patients (80%) had macrophage activation syndrome (MAS) during their disease course and 15 patients (60%) had MAS at pulmonary diagnosis. Sixteen patients had PAH, 5 had AP, and 7 had ILD. Seventeen patients (68%) were taking or recently discontinued (<1 month) a biologic agent at pulmonary symptom onset; 12 patients (48%) were taking anti-IL-1 therapy (primarily anakinra). Seventeen patients (68%) died at a mean of 10.2 months from the diagnosis of pulmonary complications.
CONCLUSION: PAH, AP, and ILD are underrecognized complications of systemic JIA that are frequently fatal. These complications may be the result of severe uncontrolled systemic disease activity and may be influenced by medication exposure.
Authors:
Yukiko Kimura; Jennifer E Weiss; Kathryn L Haroldson; Tzielan Lee; Marilynn Punaro; Sheila Oliveira; Egla Rabinovich; Meredith Riebschleger; Jordi Antón; Peter R Blier; Valeria Gerloni; Melissa M Hazen; Elizabeth Kessler; Karen Onel; Murray H Passo; Robert M Rennebohm; Carol A Wallace; Patricia Woo; Nico Wulffraat;
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Arthritis care & research     Volume:  65     ISSN:  2151-4658     ISO Abbreviation:  Arthritis Care Res (Hoboken)     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-24     Completed Date:  2013-06-17     Revised Date:  2013-07-12    
Medline Journal Info:
Nlm Unique ID:  101518086     Medline TA:  Arthritis Care Res (Hoboken)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  745-52     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 by the American College of Rheumatology.
Affiliation:
Division of Pediatric Rheumatology, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, 30 Prospect Avenue, Hackensack, NJ 07601, USA. YKimura@HackensackUMC.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Arthritis, Juvenile Rheumatoid / complications,  diagnosis*,  mortality*
Child
Child, Preschool
Cohort Studies
Cross-Sectional Studies
Female
Humans
Hypertension, Pulmonary / diagnosis*,  etiology,  mortality*
Infant
Male
Questionnaires
Registries
Retrospective Studies
Grant Support
ID/Acronym/Agency:
UL1 TR000055/TR/NCATS NIH HHS
Investigator
Investigator/Affiliation:
Leslie Abramson / ; Timothy Beukelman / ; James Birmingham / ; Suzanne Bowyer / ; Elizabeth Chalom / ; Fatma Dedeoglu / ; Polly Ferguson / ; Donald Goldsmith / ; Beth Gottlieb / ; Thomas Graham / ; J Roger Hollister / ; Anna Huttenlocher / ; Norman Ilowite / ; Lisa Imundo / ; Christi Inman / ; Rita Jerath / ; Lawrence Jung / ; Philip Kahn / ; Daniel Kingsbury / ; Marisa Klein-Gitelman / ; Thomas Lehman / ; Carol Lindsley / ; Deborah Mc- Curdy / ; Nandini Moorthy / ; Barry Myones / ; Andrew Lasky / ; Jorge Lopez-Benitez / ; Judyann Olson / ; Kathleen O'Neil / ; Kabita Nanda / ; Karin Peterson / ; Sampath Prahalad / ; Ana Quintero / ; Ann Reed / ; Sarah Ringold / ; Deborah Rothman / ; Natasha Ruth / ; Christy Sandborg / ; Kenneth Schikler / ; David Sherry / ; Nora Singer / ; Steven Spalding / ; Reema Syed / ; Kathryn Torok / ; Richard Vehe / ; Emily von Scheven / ; Andrew White / ; Ali Yalcindag / ; Lawrence Zemel /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Directed Modulation of Protein Kinase?C Isozyme Selectivity with Bisubstrate-Based Inhibitors.
Next Document:  Transcriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathop...